// App-Quantinova.ai

3590 : U.S. patients receiving resin 90Y microspheres for unresectable colorectal liver metastases: A multicenter study of 506 patients.

Researchers

Presenter

  • Andrew S. Kennedy

Principal Investigators

  • David Ball

  • Steven J. Cohen

  • Michael Savin

  • Sabine Schirm

  • Navesh K Sharma

  • Eric Wang

  • Michael Cohn

  • Douglas M. Coldwell

  • Alain Drooz

  • Edward Ehrenwald

  • Samir Kanani

  • Steven C. Rose

  • Charles W. Nutting

  • Fred M Moeslein

Medical Centers

  • University of Maryland School of Medicine, Baltimore, MD

  • Fairfax Radiological Consultants, Fairfax, VA

  • Charlotte Radiology, Charlotte, NC

  • University of Maryland Medical Center, Baltimore, MD

  • Radiology Imaging Associates, Englewood, CO

  • Fox Chase Cancer Center, Philadelphia, PA

  • Cancer Center of North Carolina, Raleigh, NC

  • James Graham Brown Cancer Center, University of Louisville, Louisville, KY

  • Beaumont Hospital, Royal Oak, Royal Oak, MI

  • Inova Fairfax Hospital, Annandale, VA

  • Abbott Northwestern Hosp, Minneapolis, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal liver metastases

  • Colorectal Cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A